Laetitia Lacroix

8 Rue Du Général Sarrail
Creteil, 94010, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets.

Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets.

Journal: Acta neuropathologica communications

Published: October 23, 2025

Seminal plasma inhibits Chlamydia trachomatis infection in vitro, and may have consequences on mucosal immunity.

Seminal plasma inhibits Chlamydia trachomatis infection in vitro, and may have consequences on mucosal immunity.

Journal: Scientific reports

Published: October 12, 2023

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.

Journal: Haematologica

Published: October 04, 2022

Complement Detection in Human Tumors by Immunohistochemistry and Immunofluorescence.

Complement Detection in Human Tumors by Immunohistochemistry and Immunofluorescence.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 13, 2021

Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules.

Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 07, 2019

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Journal: Blood

Published: June 07, 2019

Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial.

Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 23, 2019

Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.

Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.

Journal: Cancer immunology research

Published: December 14, 2018

Revisiting immune escape in colorectal cancer in the era of immunotherapy.

Revisiting immune escape in colorectal cancer in the era of immunotherapy.

Journal: British journal of cancer

Published: September 05, 2018

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine.

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine.

Journal: Frontiers in oncology

Published: July 16, 2018

B cells are associated with survival and immunotherapy response in sarcoma.

B cells are associated with survival and immunotherapy response in sarcoma.

Journal: Nature

Published: June 29, 2018

Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: February 23, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026